Saturday 17 October 2026
Export RLX’s income statement to Excel — free account
RLX Technology Inc. Sponsored ADR
RLX Consumer Defensive Tobacco
In the quarter to June 2026, revenue grew 21.9%, EPS grew 30.0%, free cash flow fell 129.3% and total debt rose 72.5%, each against the same quarter a year earlier.
1.70
0.01
−0.58%
Follow RLX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
17.92 | 22.00 | 23.30 | 32.88 |
+8 more quarters Free account |
P/S ratio |
3.55 | 4.29 | 5.51 | 7.11 | |
P/FCF ratio |
48.59 | 30.17 | 22.21 | 22.31 | |
P/Operating CF |
(245.65) | (271.68) | 61.49 | 63.16 | |
P/B ratio |
1.04 | 1.21 | 1.27 | 1.46 | |
Price to Tangible BV |
1.09 | 1.27 | 1.33 | 1.54 | |
EV/Sales |
1.58 | 2.11 | 2.74 | 4.47 | |
EV/EBITDA |
12.16 | 18.61 | 30.14 | 72.31 | |
EV/Operating CF |
13.42 | 11.18 | 8.97 | 11.31 | |
EV/FCF |
21.70 | 14.86 | 11.03 | 14.03 | |
Quick Ratio |
9.63 | 7.80 | 5.39 | 8.68 | |
Current Ratio |
10.61 | 8.53 | 5.70 | 9.30 | |
Net Debt/EBITDA |
(67.10) | (38.79) | (80.73) | (90.57) | |
Debt/Assets |
1.31% | 1.06% | 0.82% | 0.82% | |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.01 | |
Asset Turnover |
0.27 | 0.26 | 0.21 | 0.19 | |
Operating CF/Net income |
(0.30) | (0.24) | 1.09 | 1.77 | |
Capex/Depreciation |
— | — | (1.94) | — | |
Research and Development Expense of Revenue |
3.20% | 2.07% | 3.07% | 3.99% | |
Selling, General and Administrative Expense of Revenue |
21.60% | 15.60% | 19.15% | 21.09% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.04 | 0.05 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.61 | 0.53 | 0.45 | 0.37 | |
Graham Number |
0.00 | 0.00 | 2.03 | 0.00 | |
Earnings Yield |
5.58% | 4.55% | 4.29% | 3.04% | |
Free Cash Flow Yield |
2.06% | 3.31% | 4.50% | 4.48% | |
Revenue per Share |
0.11 | 0.17 | 0.13 | 0.12 | |
Operating CF per Share |
(0.01) | (0.01) | 0.04 | 0.04 | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | |
Free Cash Flow per Share |
(0.01) | (0.01) | 0.02 | 0.04 | |
Cash per Share |
1.08 | 1.14 | 1.19 | 0.99 | |
Shareholders Equity per Share |
1.88 | 1.88 | 1.84 | 1.87 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.88 | 1.88 | 1.84 | 1.87 | |
Free Cash Flow |
(9.48) | (9.98) | 29.62 | 50.61 | |
Working Capital |
1,440.36 | 1,478.36 | 1,321.15 | 1,201.38 | |
Capital Expenditures |
— | — | (16.75) | — | |
Net Current Asset Value |
1,409.72 | 1,447.68 | 1,287.85 | 1,171.98 | |
EV/EBIT |
12.16 | 18.61 | 30.14 | 72.31 | |
Capex to Sales |
0.00 | 0.00 | 0.10 | 0.00 | |
Price to Operating Income |
27.23 | 37.78 | 60.68 | 114.99 | |
| Other line items | |||||
Average Receivables |
89.33 | 87.24 | 58.35 | 51.58 | |
Average Payables |
41.83 | 72.84 | 60.27 | 48.90 | |
Average Inventory |
46.58 | 35.02 | 31.05 | 22.02 | |
Average Assets |
2,462.27 | 2,449.08 | 2,437.61 | 2,392.92 | |
Average Common Equity |
— | — | 2,229.80 | — |
Columns are period end dates